Janux Therapeutics, Inc.
Janux Therapeutics, Inc.（JANX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
janx · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$36.00
Consensus
$23.40
+73.2% upside
Low
$14.00
Median: $22 · Last Close: $13.51
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$23.40
73.2% upside
High Target
$36
166.5%
Low Target
$14
3.6%
Current Price
$13.51
as of today
Based on analyst price targets, the JANX stock price prediction for the next 12 months ranges from $14 to $36. The consensus JANX price forecast of $23.40 implies 73.2% upside from the current price of $13.51.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $13.15 | ↓ 2.69% |
1-day model range: $13.1–$13.2. Peak: $13.2 (-2.69%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · JANX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-08 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-28 | Jones Trading | Maintains | Buy→Buy |
| 2026-04-20 | Barclays | Downgrade ↓ | Overweight→Underweight |
| 2026-04-15 | UBS | Downgrade ↓ | Buy→Neutral |
| 2026-02-27 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-01-20 | Clear Street | Downgrade ↓ | Buy→Hold |
| 2026-01-16 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Janux Therapeutics, Inc. (JANX) stock. Of the recent 52 rating actions, 0 were upgrades and 3 were downgrades. 15 analysts currently cover JANX.
分析师推荐趋势
JANX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$29M
↑ 57.3% YoY
Revenue Next Year
$7M
↓ 76.3% YoY
EPS This Year
$-1.77
EPS Next Year
$-2.74
↑ 54.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast JANX EPS of $-1.77 for the current fiscal year, based on estimates from 12 analysts. The JANX revenue forecast is $29M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
JANX 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。JANX 的共识目标价为 $23.40（+73.2% 上行空间），分析师共识为 Buy。
JANX 的短期预测（明日）为 $13.15（-2.69%）。
Janux Therapeutics, Inc. 在 NASDAQ 上市，代码 JANX。JANX 在 2027 年的整体展望偏积极，在覆盖分析师中约 73% 对应 Buy 共识。
常见问题
JANX 预测 · 8 个问题根据 15 位华尔街分析师，JANX 的 12 个月平均目标价为 $23.40，最高 $36.00、最低 $14.00。若有图表，中位目标价可在上方查看。相对当前价 $13.51，隐含约 +73.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.